Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Results published from phase II trial of Immune Response's rheumatoid arthritis treatment

Dec. 1, 1998

LTA4 hydrolase inhibitors reported in development at Santen

Nov. 30, 1998

FDA advisory committee meets this week to discuss Celebrex NDA

Nov. 30, 1998

Immunex files sBLA for Enbrel as treatment for juvenile rheumatoid arthritis

Nov. 27, 1998

British Biotech expands pipeline of MMP inhibitors

Nov. 27, 1998

Amarillo Biosciences initiates phase III clinical trial with oral interferon alfa

Nov. 27, 1998

Merck & Co. synthesizes potent and orally active p38 inhibitor

Nov. 25, 1998

COX-2-specific inhibitor from Merck filed for approval with FDA

Nov. 24, 1998

Immunex receives U.S. patent protection for TACE

Nov. 24, 1998

Antiinflammatory tetrazoles in development at Ono

Nov. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...